FGPMX
Price
$27.18
Change
+$1.21 (+4.66%)
Updated
Apr 10 closing price
Net Assets
1.26B
OGMYX
Price
$33.08
Change
+$0.99 (+3.09%)
Updated
Apr 10 closing price
Net Assets
2.34B
Ad is loading...

FGPMX vs OGMYX

Header iconFGPMX vs OGMYX Comparison
Open Charts FGPMX vs OGMYXBanner chart's image
Franklin Gold and Precious Metals R6
Price$27.18
Change+$1.21 (+4.66%)
VolumeN/A
Net Assets1.26B
Invesco Gold & Special Minerals Y
Price$33.08
Change+$0.99 (+3.09%)
VolumeN/A
Net Assets2.34B
FGPMX vs OGMYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FGPMX vs. OGMYX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGPMX is a Buy and OGMYX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
OGMYX has more cash in the bank: 2.34B vs. FGPMX (1.26B). FGPMX pays higher dividends than OGMYX: FGPMX (8.78) vs OGMYX (0.80). FGPMX was incepted earlier than OGMYX: FGPMX (12 years) vs OGMYX (15 years). OGMYX (0.86) is less costly to investors than FGPMX (0.63). OGMYX is a more actively managed with annual turnover of: 30.00 vs. FGPMX (14.50). OGMYX has a lower initial minimum investment than FGPMX: OGMYX (1000) vs FGPMX (1000000). FGPMX annual gain was more profitable for investors over the last year : 44.02 vs. OGMYX (31.15). FGPMX return over 5 years is better than : 103.41 vs. OGMYX (81.82).
FGPMXOGMYXFGPMX / OGMYX
Total Expense Ratio0.550.8664%
Annual Report Gross Expense Ratio0.630.8673%
Fund Existence12 years15 years-
Gain YTD34.83924.815140%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.26B2.34B54%
Annual Yield % from dividends8.780.801,100%
Returns for 1 year44.0231.15141%
Returns for 3 years12.8410.53122%
Returns for 5 years103.4181.82126%
Returns for 10 years163.73191.6585%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USEMX19.48N/A
N/A
Victory Emerging Markets
HAGIX68.58N/A
N/A
Carillon Eagle Mid Cap Growth I
LMORX32.50N/A
N/A
Patient Opportunity R
TARKX24.20N/A
N/A
Tarkio
MRJIX10.39N/A
N/A
Morgan Stanley Multi-Asset Real Return I